Targeting and Disrupting HIV with Engineered Homing Endonucleases
Author Information
Author(s): Aubert Martine, Ryu Byoung Y., Banks Lindsey, Rawlings David J., Scharenberg Andrew M., Jerome Keith R.
Primary Institution: Fred Hutchinson Cancer Research Center
Hypothesis
Can engineered homing endonucleases effectively target and disrupt integrated HIV proviral DNA in latently infected cells?
Conclusion
The study demonstrates that engineered homing endonucleases can selectively target and induce mutations in integrated HIV proviral DNA, potentially disabling the virus.
Supporting Evidence
- Engineered homing endonucleases can efficiently target integrated HIV proviral DNA.
- Targeted mutagenesis led to loss of reporter gene expression in the study's model.
- The approach offers a potential new strategy for curing HIV infection.
Takeaway
Scientists are trying to use special enzymes to break the DNA of HIV inside infected cells, which could help cure people from the virus.
Methodology
The researchers developed an in vitro culture model of viral latency and used engineered homing endonucleases to introduce DNA double-stranded breaks in integrated proviral DNA.
Limitations
The study primarily used in vitro models, and the clinical applicability of the findings remains to be established.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website